The Rutgers Krieger Klein Alzheimer's Research Center has received a $1.5 million philanthropic gift from the Norman and Mary ...

Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...

"Spinogenix’s Alzheimer’s drug touts disease-modifying potential in Phase IIa study" was originally created and published by ...

B. Joy Snider's clinic focuses on early detection of memory issues, using biomarkers for precise Alzheimer's diagnosis and ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

Overall, Contreras concluded that DM-BUP represents a promising advancement in Alzheimer care, offering a safer, effective, ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

Alzheimer’s disease affects millions of people around the world, slowly damaging memory, thinking, and behavior. For decades, scientists have searched for a way to stop or even slow down this ...

Alzheimer’s disease is the most common cause of dementia—a general term for loss of memory, language, and other thinking abilities). Alzheimer’s disease accounts for 60 to 80 percent of dementia cases ...

A new statewide spatial analysis of Alzheimer's disease and related dementias (ADRD) has uncovered significant disparities in ...

Where you live in Maryland will likely affect your quality of care if you are diagnosed with Alzheimer’s disease, according ...